- Home
- BFST vs BVS Comparison
BFST vs BVS Comparison
Compare BFST & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BFST | BVS |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 982.2M |
| IPO Year | 2014 | 2016 |
Fundamental Metrics
Financial Performance| Metric | BFST | BVS |
|---|---|---|
| Price | $31.44 | $14.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $32.75 | $14.00 |
| AVG Volume (30 Days) | 179.3K | ★ 727.3K |
| Earning Date | 04-27-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.23% | N/A |
| EPS Growth | 23.45 | ★ 163.46 |
| EPS | ★ 1.37 | 0.52 |
| Revenue | $10,704,000.00 | ★ $568,087,000.00 |
| Revenue This Year | $22.71 | $7.52 |
| Revenue Next Year | $5.02 | $7.06 |
| P/E Ratio | ★ $22.85 | $27.63 |
| Revenue Growth | ★ 1.20 | N/A |
| 52 Week Low | $22.56 | $6.26 |
| 52 Week High | $32.53 | $15.89 |
Technical Indicators
Market Signals| Indicator | BFST | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 53.63 | 60.70 |
| Support Level | $31.26 | $8.21 |
| Resistance Level | $32.46 | $14.92 |
| Average True Range (ATR) | 0.47 | 0.50 |
| MACD | -0.07 | -0.10 |
| Stochastic Oscillator | 55.27 | 65.20 |
Price Performance
Historical ComparisonAbout BFST Business First Bancshares Inc.
Business First Bancshares Inc is a bank holding company. The company's services include personal and commercial banking, treasury management, and wealth solutions. It provides a range of financial services to small-to-midsized businesses and professionals. The company generates the majority of its revenues from interest income on loans, customer service and loan fees, and interest income from securities.
About BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.